OrthoPediatrics Corp. (KIDS) — Analyst outlook / Analyst consensus target is. Based on 13 analyst ratings, the consensus is bullish — 12 Buy, 1 Hold.
The consensus price target is $24.00 (low: $18.00, high: $34.00), representing an upside of 34.4% from the current price $17.86.
Analysts estimate Earnings Per Share (EPS) of $-1.13 and revenue of $0.20B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-1.64 vs est $-1.13 (missed -45.2%). 2025: actual $-1.69 vs est $-1.25 (missed -34.9%). Analyst accuracy: 72%.
KIDS Stock — 12-Month Price Forecast
$24.00
▲ +34.38% Upside
Average Price Target
Based on 13 Wall Street analysts offering 12-month price targets for OrthoPediatrics Corp., the average price target is $24.00, with a high forecast of $34.00, and a low forecast of $18.00.
The average price target represents a +34.38% change from the last price of $17.86.
Highest Price Target
$34.00
Average Price Target
$24.00
Lowest Price Target
$18.00
KIDS Analyst Ratings
Buy
Based on 13 analysts giving stock ratings to OrthoPediatrics Corp. in the past 3 months
EPS Estimates — KIDS
72%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual –$1.64
vs Est –$1.13
▼ 31.1% off
2025
Actual –$1.69
vs Est –$1.25
▼ 25.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — KIDS
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.205B
vs Est $0.203B
▲ 0.9% off
2025
Actual $0.236B
vs Est $0.235B
▲ 0.6% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
